Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  90,839 results for ""Moxifloxacin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Moxifloxacin HCl -loaded Cellulose Acetate Butylate In Situ Forming Gel for Periodontitis Treatment.

  • Authors : Thammasut W; Program of Pharmaceutical Engineering, Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 73000, Thailand.; Rojviriya C

Subjects: Cellulose*/Cellulose*/Cellulose*/analogs & derivatives ; Cellulose*/Cellulose*/Cellulose*/chemistry ; Periodontitis*/Periodontitis*/Periodontitis*/drug therapy

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Oct 14; Vol. 25 (7), pp. 242. Date of Electronic Publication: 2024 Oct 14.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Characteristics of Moxifloxacin-Related Arrhythmias and Development of a Predictive Nomogram: A Case Control Study.

  • Authors : Li P; Department of Pharmacy, Medical Supplies Center, Chinese People's Liberation Army General Hospital, Beijing, China.; Chinese People's Liberation Army Medical School, Beijing, China.

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/adverse effects ; Nomograms* ; Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/chemically induced

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Nov; Vol. 64 (11), pp. 1351-1360. Date of Electronic Publication: 2024 Aug 02.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of moxifloxacin as a mono-antibiotic therapy for hidradenitis suppurativa: A retrospective cohort study.

  • Authors : Vu D; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: .; Park M

Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/drug therapy ; Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use ; Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/administration & dosage

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 583-585. Date of Electronic Publication: 2024 Jun 01.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

Read More Add to Saved list
×
Academic Journal

Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures.

  • Authors : Walter K; Division of Infection Immunology, Research Center Borstel, Leibniz Lung Center, Borstel, Germany.; German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany.

Subjects: Nitroimidazoles*/Nitroimidazoles*/Nitroimidazoles*/therapeutic use ; Nitroimidazoles*/Nitroimidazoles*/Nitroimidazoles*/administration & dosage ; Nitroimidazoles*/Nitroimidazoles*/Nitroimidazoles*/pharmacology

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Oct 01; Vol. 79 (10), pp. 2607-2610.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects ; Diarylquinolines*/Diarylquinolines*/Diarylquinolines*/therapeutic use

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 1003-1014. Date of Electronic Publication: 2024 May 17.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use.

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Iris Diseases*/Iris Diseases*/Iris Diseases*/chemically induced

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Sep; Vol. 32 (7), pp. 1368-1373. Date of Electronic Publication: 2023 Aug 31.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bilateral acute iris transillumination syndrome following COVID-19 infection and moxifloxacin use.

  • Authors : Lazari K; Department of Ophthalmology, University Hospital of Larissa, Larissa, Greece.; Androudi S

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/complications ; SARS-CoV-2*

  • Source: Clinical & experimental optometry [Clin Exp Optom] 2024 Sep; Vol. 107 (7), pp. 764-766. Date of Electronic Publication: 2023 Sep 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8703442 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe.

Subjects: Linezolid*/Linezolid*/Linezolid*/pharmacology ; Linezolid*/Linezolid*/Linezolid*/therapeutic use ; Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Sep; Vol. 30 (9), pp. Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691

Record details

Read More Add to Saved list
×
Academic Journal

A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis.

  • Authors : Deng G; Pulmonary Diseases Department, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China; National Clinical Research Center for Infectious Disease (Shenzhen), Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis), Shenzhen Clinical Research Center for Tuberculosis, Shenzhen, China.

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Diarylquinolines*/Diarylquinolines*/Diarylquinolines*/therapeutic use

  • Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep; Vol. 24 (9), pp. 940-941. Date of Electronic Publication: 2024 May 17.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacin.

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/administration & dosage ; Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/pharmacokinetics ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jul; Vol. 90 (7), pp. 1711-1727. Date of Electronic Publication: 2024 Apr 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  90,839 results for ""Moxifloxacin""